Severe Allergic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Indian Pharmacopoeia Commission's advisory alerts users about Meftal's dangers, specifically its active ingredient mefenamic acid, linked to severe allergic reactions like DRESS syndrome. This syndrome, a type 4 hypersensitivity reaction, causes skin issues, fever, and organ abnormalities. Meftal's risks extend to stomach ulcers, bleeding, and kidney problems with prolonged use. Users are urged to consult doctors, avoid self-medication, and prioritize safety, emphasizing informed decision-making when considering this widely used painkiller.

FDA Advisory Committee Votes: neffy Data Support a Favorable Benefit-Risk Assessment in Adults and in Children <18 years of age and ≥30 kg If Approved, neffy Will Become the First Needle-Free... | May 11, 2023

FDA Advisory Committee Votes: neffy Data Support a Favorable Benefit-Risk Assessment in Adults (16:6 in Favor) and in Children &lt;18 years of age and ≥30...

Background Currently, disease control in patients with severe eosinophilic asthma is not optimistic. Competing endogenous RNA (ceRNA) networks have been found to play a key role in asthma in recent years. However, it is unclear whether ceRNA networks play an important part in severe eosinophilic asthma. Methods Firstly, gene expression profiles related to severe eosinophilic asthma were downloaded from the Gene Expression Omnibus (GEO) database. Secondly, the key modules were identified by the weighted gene co-expression network analysis (WGCNA). Thirdly, genes in modules highly associated wit...

Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost-effective treatment option in the country. Glenmark is the first company in the world to laun...